Patents by Inventor Sumit Madan

Sumit Madan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230285301
    Abstract: The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: May 15, 2023
    Publication date: September 14, 2023
    Applicant: Sun Pharmaceutical Industries Limited
    Inventors: Amit KUMAR, Ravindra AGARWAL, Pulak Kumar METIA, Kalaiselvan RAMARAJU, Sumit MADAN, Romi Barat SINGH
  • Patent number: 11690805
    Abstract: The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Grant
    Filed: December 14, 2021
    Date of Patent: July 4, 2023
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Amit Kumar, Ravindra Agarwal, Pulak Kumar Metia, Kalaiselvan Ramaraju, Sumit Madan, Romi Barat Singh
  • Publication number: 20220105040
    Abstract: The present invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each discrete unit comprising quetiapine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: December 14, 2021
    Publication date: April 7, 2022
    Applicant: Sun Pharmaceutical Industries Limited
    Inventors: Amit KUMAR, Ravindra AGARWAL, Pulak Kumar METIA, Kalaiselvan RAMARAJU, Sumit MADAN, Romi Barat SINGH
  • Publication number: 20220023372
    Abstract: The present invention relates to a composite extract of Cocculus hirsutus for use in the prevention and treatment of dengue and its pharmaceutical compositions. Further, it provides for a stable pharmaceutical composition comprising a therapeutically effective amount of the said extract for use in the treatment of dengue virus infection in a mammal. It also provides for a method for reducing viral load in the treatment of dengue virus infection by administering the composite extract or its pharmaceutical composition to a mammal in need thereof.
    Type: Application
    Filed: December 9, 2019
    Publication date: January 27, 2022
    Inventors: Kaushal NAYYAR, Upasana ARORA, Srinivas PALLA, Mohan PRASAD, Saravanan A, Sumit MADAN, Ruchi SOOD, Navin KHANNA, Ankur PODDAR, Rahul SHUKLA, Mudgal KOTHEKAR
  • Patent number: 10342774
    Abstract: The present invention relates to a topical pharmaceutical composition comprising acitretin and a process for its preparation. It also relates to a method of treating skin disorders by administering said topical pharmaceutical composition.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: July 9, 2019
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Rathinasabapathy Venkateshwaran, Vikas Jain, Vaibhav Dubey, Sumit Madan, Vinod Kumar Arora, Rajesh Rao
  • Publication number: 20180369182
    Abstract: The present invention relates to a topical pharmaceutical composition comprising acitretin and a process for its preparation. It also relates to a method of treating skin disorders by administering said topical pharmaceutical composition.
    Type: Application
    Filed: August 10, 2018
    Publication date: December 27, 2018
    Inventors: Rathinasabapathy Venkateshwaran, Vikas Jain, Vaibhav Dubey, Sumit Madan, Vinod Kumar Arora, Rajesh Rao
  • Patent number: 10123987
    Abstract: The present invention relates to a topical pharmaceutical composition comprising acitretin and a process for its preparation. It also relates to a method of treating skin disorders by administering said topical pharmaceutical composition.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: November 13, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Rathinasabapathy Venkateshwaran, Vikas Jain, Vaibhav Dubey, Sumit Madan, Vinod Kumar Arora, Rajesh Rao
  • Patent number: 10022348
    Abstract: The present invention relates to a topical solution comprising a retinoid or its pharmaceutically acceptable salts thereof and process of preparing it.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: July 17, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Sanjay Kumar Motwani, Vaibhav Dubey, Shashikanth Isloor, Vinod Kumar Arora, Vishnu Datta Maremanda, K. K. Janakiraman, Sumit Madan, Subodh Deshmukh
  • Publication number: 20180071240
    Abstract: The present invention relates to a modified-release, once-daily, oral pharmaceutical composition comprising isotretinoin and a process for its preparation. In some embodiments, the disclosure is directed to a modified-release, oral pharmaceutical composition comprising isotretinoin or a pharmaceutically acceptable salt, ester or a derivative thereof; and a release modifying agent, wherein the composition is suitable for once daily administration. In some embodiments, the disclosure is directed to a modified-release, oral pharmaceutical composition comprising isotretinoin, wherein the composition comprises an immediate-release component; and a modified-release component comprising a release modifying agent, and wherein the composition is suitable for once daily administration.
    Type: Application
    Filed: November 24, 2017
    Publication date: March 15, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Sumit MADAN, Anuj Kumar FANDA, Pankaj Prabhakar AMRUTKAR, Rajesh RAO, Jitendra KAWADKAR, Vasu Kumar KAKUMANU, Ravi KOCHHAR, Romi Barat SINGH, Dileep JAMI, Lokesh GARG, Sandipan ROY
  • Publication number: 20170326092
    Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin with a reduced dose. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: August 2, 2017
    Publication date: November 16, 2017
    Inventors: Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Harish Kumar MADAN, Ravi KOCHHAR, Simon Santosh JENA, Rajesh RAO, Anuj Kumar FANDA, Romi Barat SINGH
  • Publication number: 20170326091
    Abstract: The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: August 1, 2017
    Publication date: November 16, 2017
    Inventors: Harish Kumar MADAN, Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Ravi KOCHHAR
  • Patent number: 9750711
    Abstract: The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: September 5, 2017
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Harish Kumar Madan, Rathinasabapathy Venkateshwaran, Sumit Madan, Ravi Kochhar
  • Publication number: 20170165218
    Abstract: The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: February 28, 2017
    Publication date: June 15, 2017
    Inventors: Harish Kumar MADAN, Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Ravi KOCHHAR
  • Publication number: 20160346241
    Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin having enhanced bioavailability, wherein said composition is in the form of a solid dispersion comprising isotretinoin and a pharmaceutically acceptable matrix. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: December 3, 2015
    Publication date: December 1, 2016
    Inventors: Pankaj Prabhakar AMRUTKAR, Sumit MADAN, Ravi KOCHHAR, Subodh DESHMUKH
  • Publication number: 20160338985
    Abstract: The present invention relates to a topical solution comprising a retinoid or its pharmaceutically acceptable salts thereof and process of preparing it.
    Type: Application
    Filed: August 2, 2016
    Publication date: November 24, 2016
    Inventors: Sanjay Kumar MOTWANI, Vaibhav DUBEY, Shashikanth ISLOOR, Vinod Kumar ARORA, Vishnu Datta MAREMANDA, K. K. JANAKIRAMAN, Sumit MADAN, Subodh DESHMUKH
  • Publication number: 20160287583
    Abstract: The present invention relates to oral dispersible compositions comprising a DPP-IV inhibitor and processes for their preparation. It further relates to a method of treating diabetes by administering said oral dispersible compositions.
    Type: Application
    Filed: November 13, 2014
    Publication date: October 6, 2016
    Applicant: Ranbaxy Laboratories Limited
    Inventors: Vinod Kumar ARORA, Rathinasabapathy VENKATESHWARAN, Sumit MADAN
  • Publication number: 20160271092
    Abstract: The present invention relates to a topical pharmaceutical composition comprising acitretin and a process for its preparation. It also relates to a method of treating skin disorders by administering said topical pharmaceutical composition.
    Type: Application
    Filed: October 30, 2014
    Publication date: September 22, 2016
    Inventors: Rathinasabapathy VENKATESHWARAN, Vikas JAIN, Vaibhav DUBEY, Sumit MADAN, Vinod Kumar ARORA, Rajesh RAO
  • Publication number: 20160256474
    Abstract: The present invention relates to topical spray compositions comprising halobetasol, an emollient, a non-aqueous solvent, and a propellant. It also relates to a process for the preparation of the topical spray compositions. It further relates to a method of treating topical skin condition by administering said topical spray compositions.
    Type: Application
    Filed: September 22, 2014
    Publication date: September 8, 2016
    Inventors: Anil RANA, Sumit MADAN, Anupam TREHAN, Vinod Kumar ARORA
  • Publication number: 20160256462
    Abstract: The present invention relates to oral liquid pharmaceutical compositions comprising a DPP-IV inhibitor and processes for preparing the oral liquid pharmaceutical compositions. The invention also relates to oral liquid pharmaceutical compositions comprising a DPP-IV inhibitor and processes for preparing the oral liquid pharmaceutical compositions devoid of sugar based sweeteners. It further relates to a method of treating diabetes by administering said oral liquid pharmaceutical compositions.
    Type: Application
    Filed: September 24, 2014
    Publication date: September 8, 2016
    Inventors: Vinod Kumar ARORA, Sumit MADAN, Rathinasabapathy VENKATESHWARAN
  • Publication number: 20160235766
    Abstract: The present invention relates to propellant-free topical spray compositions of halobetasol comprising halobetasol, an emollient, and a non-aqueous solvent. It also relates to a process for the preparation of the propellant-free topical spray compositions. It further relates to a method of treating topical skin condition by administering said 5 propellant-free topical spray compositions.
    Type: Application
    Filed: September 24, 2014
    Publication date: August 18, 2016
    Inventors: Anil RANA, Sumit MADAN, Anupam TREHAN, Vinod Kumar ARORA